Choate represented Transformation Capital in the transaction, while Cuatrecasas represented Vesalius Biocapital III Partners.SWORD Health closed a $25M Series B financing, in which Transformation Capital acted as…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
